Using Screening Tests to Predict Aberrant Use of Opioids in Chronic Pain Patients: Caveat Emptor

This article highlights common metrics for evaluating the clinical utility of screening tests in predicting aberrant opioid use. In addition, it explores a series of considerations key to developing clinical guidelines for interpreting the results of screeners in this context.